Lincoln Pharmaceuticals consolidated net profit declines 12.40% in the March 2022 quarter

19 May 2022 , 02:26 PM

Net profit of Lincoln Pharmaceuticals declined 12.40% to Rs 11.02 crore in the quarter ended March 2022 as against Rs 12.58 crore during the previous quarter ended March 2021. Sales rose 28.91% to Rs 102.59 crore in the quarter ended March 2022 as against Rs 79.58 crore during the previous quarter ended March 2021. For the full year,net profit rose 11.42% to Rs 69.36 crore in the year ended March 2022 as against Rs 62.25 crore during the previous year ended March 2021. Sales rose 11.30% to Rs 472.12 crore in the year ended March 2022 as against Rs 424.19 crore during the previous year ended March 2021.

Particulars	Quarter Ended	Year Ended
?	Mar. 2022	Mar. 2021	% Var.	Mar. 2022	Mar. 2021	% Var.
Sales	102.59	79.58	29	472.12	424.19	11
OPM %	17.01	19.16	–	20.22	20.55	–
PBDT	18.77	17.20	9	104.03	91.28	14
PBT	16.77	15.31	10	95.94	83.72	15
NP	11.02	12.58	-12	69.36	62.25	11

Powered by Capital Market – Live News